These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34190404)

  • 21. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-infarct treatment with [Pyr1]apelin-13 exerts anti-remodelling and anti-apoptotic effects in rats' hearts.
    Azizi Y; Imani A; Fanaei H; Khamse S; Parvizi MR; Faghihi M
    Kardiol Pol; 2017; 75(6):605-613. PubMed ID: 28181211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Danqi soft capsule prevents infarct border zone remodelling and reduces susceptibility to ventricular arrhythmias in post-myocardial infarction rats.
    Ma S; Ma J; Mai X; Zhao X; Guo L; Zhang M
    J Cell Mol Med; 2019 Aug; 23(8):5454-5465. PubMed ID: 31232519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction.
    Kompa AR; Khong FL; Zhang Y; Nguyen C; Edgley AJ; Woodman OL; McLachlan G; Kelly DJ
    Life Sci; 2022 Jan; 289():120220. PubMed ID: 34902438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Tarkia M; Stark C; Haavisto M; Kentala R; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teräs M; Pietilä M; Nyman L; Duvall E; Saukko P; Levijoki J; Roivainen A; Saraste A; Knuuti J
    Heart; 2016 Mar; 102(6):465-71. PubMed ID: 26762238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
    Gravning J; Ørn S; Kaasbøll OJ; Martinov VN; Manhenke C; Dickstein K; Edvardsen T; Attramadal H; Ahmed MS
    PLoS One; 2012; 7(12):e52120. PubMed ID: 23284892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.
    Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X
    Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
    Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
    Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
    Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction.
    Liehn EA; Merx MW; Postea O; Becher S; Djalali-Talab Y; Shagdarsuren E; Kelm M; Zernecke A; Weber C
    J Cell Mol Med; 2008 Apr; 12(2):496-506. PubMed ID: 18088392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of infarct healing and left ventricular remodelling in patients with reperfused ST segment elevation myocardial infarction using comprehensive magnetic resonance imaging.
    Ganame J; Messalli G; Masci PG; Dymarkowski S; Abbasi K; Van de Werf F; Janssens S; Bogaert J
    Eur Radiol; 2011 Apr; 21(4):693-701. PubMed ID: 20865262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
    de Vries MR; Ewing MM; de Jong RCM; MacArthur MR; Karper JC; Peters EAB; Nordzell M; Karabina SAP; Sexton D; Dahlbom I; Bergman A; Mitchell JR; Frostegård J; Kuiper J; Ninio E; Jukema JW; Pettersson K; Quax PHA
    J Intern Med; 2021 Jul; 290(1):141-156. PubMed ID: 33342002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.
    Cheng Z; Ou L; Liu Y; Liu X; Li F; Sun B; Che Y; Kong D; Yu Y; Steinhoff G
    Cardiovasc Res; 2008 Dec; 80(3):425-34. PubMed ID: 18676396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway.
    He Q; Zhou W; Xiong C; Tan G; Chen M
    Mol Med Rep; 2015 Jan; 11(1):374-8. PubMed ID: 25323011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
    Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
    J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.